Primus Capital completed the acquisition of a majority stake in Prendio and BioProcure.

Primus Capital, a private equity firm, completed the acquisition of a majority stake in biotechnology companies Prendio and BioProcure. Financial terms were not disclosed. “We’ve spent over 15 years helping leading biotech companies save time and money to accelerate research and development as they strive to deliver essential therapies to the world. Prendio and BioProcure are thrilled to partner with Primus to accelerate our growth and expand the mission-critical support we deliver to our clients. Primus’ investment, combined with their deep SaaS expertise and valuable industry experience, will allow us to further accelerate the development of our leading life science eProcurement platform and service offerings," Vincent Bologna, Prendio Co-Founder and CEO.